Actinium Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant or adoptive cell therapies.
Actinium Pharmaceuticals stock last closed at $1.20, down 0.83% from the previous day, and has decreased 83.26% in one year. It has underperformed other stocks in the Biotechnology industry by 0.06 percentage points. Actinium Pharmaceuticals stock is currently +16.62% from its 52-week low of $1.03, and -88.28% from its 52-week high of $10.24.
As of Apr 21, 2025, there are 31.2M shares of ATNM outstanding. The market capitalization of ATNM is $37.44M. In the past 24 hours, 259,402 ATNM shares were traded.
How to Buy Actinium Pharmaceuticals Stock
Wondering how to invest in Actinium Pharmaceuticals stock? Here's how.
Decide where to buy Actinium Pharmaceuticals stock: You need to decide on an online brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you choose where to buy Actinium Pharmaceuticals stock.
Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
Deposit funds into your investment account: Pick your payment method and add your info.
Analyze Actinium Pharmaceuticals stock: The Actinium Pharmaceuticals ticker symbol is ATNM. Is Actinium Pharmaceuticals stock a good investment? Should you buy shares of ATNM? How do ATNM's underlying business fundamentals look? Do top analysts think Actinium Pharmaceuticals is a good buy? Why has ATNM's stock price moved recently? (Hint: Our stock market research tools can help you figure out if ATNM is a good stock to buy).
Execute your ATNM trade: Decide if you will purchase ATNM shares at the current market price or use a limit order to purchase ATNM stock at a given price.
Keep tabs on your ATNM position: Create a watchlist to the latest updates on your position in Actinium Pharmaceuticals stock.
Step 1: Decide where to buy Actinium Pharmaceuticals stock
You will need a brokerage account in order to access the NYSEMKT market and buy ATNM stock.
A brokerage account allows you to buy and sell a number of financial instruments, including stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
We believe that eToro is the best stock brokerage. eToro gives you:
Invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
Access to world markets: From Technology to Financial Services, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by signing up for an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create your brokerage account
Now that you've picked your brokerage, it's time to fill out some personal details so you are able to invest in ATNM stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Actinium Pharmaceuticals stock
Once you have identified the best place to buy Actinium Pharmaceuticals stock, it's crucial to research their stock before you invest, so you truly comprehend the risk as well as the opportunity.
Actinium Pharmaceuticals quick stats
ATNM Price
$1.20
1w %
-9.09%
1y %
-83.26%
5y %
-83.04%
P/E
-0.94x
P/B
1.14x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$38.24M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$37.44M
Next Earnings
Apr 24, 2025
Next Dividend
N/A
Fundamentals of Actinium Pharmaceuticals
WallStreetZen was designed to help everyday investors do more accurate fundamental analysis in less time.
Last year, ATNM revenue was $0.00. Over the past three year, ATNM's revenue has increased by -100% per year. This was slower than the Biotechnology industry average of 44.31%.
No, Actinium Pharmaceuticals doesn't provide an income stream by paying out dividends.
What others are saying about ATNM
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Execute your ATNM trade
You have two main options:
Market order: A market order is an order to buy or sell a security at the best available price. Market orders are generally fine for most investors.
Limit order: A limit order allows you to buy or sell a security at a specific price (or better). If you want to make sure you're buying or selling at a specific dollar amount, use a limit order.
Hit the Open Trade button and eToro will execute the order.
If you want additional assistance buying stocks on eToro, watch the helpful video below:
How much does it cost to buy one Actinium Pharmaceuticals share?
As of Apr 21, 2025, it costs $1.20 to buy one share of Actinium Pharmaceuticals stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.6, you can buy 0.5 shares of ATNM.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.